Published Online First: 20 July 2007. doi:10.1136/ard.2006.068882
Annals of the Rheumatic Diseases 2008;67:735-740
Copyright © 2008 BMJ Publishing Group Ltd & European League Against Rheumatism
Biochemical basis of the effect of chondroitin sulphate on osteoarthritis articular tissues
J Monfort 1,
J-P Pelletier 2,
N Garcia-Giralt 1,
J Martel-Pelletier 2
1 Hospital del Mar, Passeig del Mar, Barcelona, Spain
2 Osteoarthritis Research Unit, University of Montreal Hospital Centre, Notre-Dame Hospital, Montreal, Quebec, Canada
Correspondence to:
Johanne Martel-Pelletier, Osteoarthritis Research Unit, University of Montreal Hospital Centre, Notre-Dame Hospital, 1560 rue Sherbrooke Est, Montreal, Quebec, Canada H2L 4M1; jm{at}martelpelletier.ca
ABSTRACT
Osteoarthritis is a chronic disease characterised by irreversible damage to joint structures, including loss of articular cartilage, osteophyte formation, alterations in the subchondral bone and synovial inflammation. Pain, functional disability and impairment of health-related quality of life are major complaints in patients with osteoarthritis. Several compounds have been investigated for their positive effects on the relief of clinical symptoms and improvement of structural changes in osteoarthritis. It has been shown that chondroitin sulphate interferes with the progression of structural changes in joint tissues and is used in the management of patients with osteoarthritis. This review summarises data from relevant reports describing the mechanisms of action of chondroitin sulphate involved in the beneficial effects of the drug.
Terms and conditions relating to subscriptions purchased online ¦ Website terms and conditions ¦ Privacy policy
Copyright © 2008 BMJ Publishing Group Ltd & European League Against Rheumatism